1-(Oxetan-3-yl)piperazine oxalate is a heterocyclic organic compound featuring a piperazine ring linked to an oxetane moiety, presented as its oxalate salt. This specific salt form is often employed to enhance the compound's stability, crystallinity, and handling properties in pharmaceutical research and development. This compound serves as a key synthetic intermediate in medicinal chemistry. Its primary application is in the synthesis of novel pharmaceutical candidates, particularly those targeting protein kinases. The oxetane ring is a valuable bioisostere for carbonyl or other functional groups, often used to improve metabolic stability, solubility, and overall drug-like properties of lead molecules. The piperazine moiety is a common pharmacophore found in numerous bioactive molecules, contributing to binding affinity and pharmacokinetic profiles. As a specialized building block, it is utilized in the discovery and optimization of potential therapeutic agents, especially within oncology and other disease areas where kinase inhibition is a validated strategy. Its use is confined to research and development settings for the preparation of more complex active pharmaceutical ingredients (APIs) or probes.